Company Profile

L.VAD Technology Inc (AKA: CardioPlus Inc~ViaDerm LLC)
Profile last edited on: 2/7/2023      CAGE: 6LLV1      UEI: W1LMB8B7QS45

Business Identifier: interruptible, heart assist devices for treatment of heart failure
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

46701 North Commerce Center Drive
Plymouth, MI 48170
   (734) 233-3985
Location: Single
Congr. District: 06
County: Wayne

Public Profile

L VAD Technology, a firm company dedicated to the research and development of mechanical systems for treating heart failure. The company has developed the CardioPlus Device. CardioPlus functions like the intraaortic balloon pump, for 30 years, the gold standard for hospital treatment of acute heart failure. The CardioPlus is more powerful than the balloon pump and allows the CHF patient to live at home and resume many normal activities. The device contains only 2 implanted components: 1) A one ounce, 5", 60cc pump implanted in the aorta, has no valves, inflates and deflates using room air. and 2) A proprietary connector, precovered with patientÂ’s own skin cells to promote stability, allowing detachment from the drive unit. The drive unit is external, detachable, and readily replaceable. One version is battery-powered, weighs 5 pounds and is worn in a vest. The other looks like carry-on luggage, has wheels and uses house current. CardioPlus simple, elegant design has demonstrated it can: Improve advanced heart failure patients by at least one functional class, relieve symptons of CHF, reduce or eliminate need for Inotropic medications. Be turned on and off with a simple switch without risk of emboli, without use of anticoagulants.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 2 NIH $1,764,299
Project Title: Novel, Long-Term Percutaneous Access Device for Chronic Therapy
2005 2 NIH $1,086,566
Project Title: Long-Term Percutaneous Access Device for Home Therapies
1990 2 NIH $550,000
Project Title: Precutaneous access device for peritoneal dialysis
1988 2 NIH $550,000
Project Title: Mechanical auxiliary ventricle
1984 1 NIH $50,000
Project Title: Percutaneous system for energy transmission

Key People / Management

  Adrian Kantrowitz -- President

  Paul S Freed -- Vice President

  Adrian Kantrowitz

  Daniel Wadsworth

Company News

There are no news available.